Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
life sciences
national blog main
san francisco blog main
san francisco top stories
akcea therapeutics
alnylam pharmaceuticals
andrew fire
boston
boston blog main
boston top stories
cannabidiol
craig mello
dravet syndrome
drugs
epidiolex
fen-phen
fenfluramine
gw pharmaceuticals
hereditary transthyretin amyloidosis
inotersen
john maraganore
lennox-gastaut syndrome
national top stories
new york blog main
new york top stories
nobel prize
onpattro
patisiran
pfizer
rna interference
san diego blog main
san diego top stories
san francisco
tafamidis
vyndaqel
zogenix
What
approved
3
×
drug
fda
medicine
pharmaceuticals
3
×
adamis
administration
afternoon
ago
allergy
alnylam
alnylam’s
alternative
battle
cannabis
cheaper
clear
compete
corporation
cost
criticized
data
derivative
directly
epilepsy
epipen
food
form
gets
gw
gw’s
heavily
history
it’ll
landmark
making
manufacturer
marijuana
market
medication
Language
Current search:
pharmaceuticals
×
approved
×
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@theverge.com
6 years ago
Cheaper alternative to EpiPen allergy shot approved by FDA
